AstraZeneca investors baulk at $400 billion Bristol Myers talks

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 1 hour ago

Deutsche Bank sees cautious positioning despite market resilience

Investing.com

stocksabout 4 hours ago

UBS now expects AI capex to reach nearly $1tn this year and around $1.4tn by 2027

Investing.com

stocksabout 5 hours ago

US fashion council CEO Kolb resigns after clash with runway show protesters

Investing.com